ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Roche seeks approval for COVID-19, flu combo test in Japan

New PCR exam by Swiss drugmaker comes as hospitals brace for winter flu season

Swiss pharmaceutical giant Roche will soon apply for approval in Japan of its reagent that detects COVID-19 and the seasonal influenza virus at the same time.

TOKYO -- Swiss pharmaceutical giant Roche will soon apply for approval in Japan of its reagent that detects COVID-19 and the seasonal influenza virus at the same time, Nikkei has learned.

The reagent can detect the virus with a high degree of accuracy if combined with Roche's testing equipment owned by medical institutions and testing companies. That also reduces the burden on patients and medical workers who are bracing for the double threat of COVID-19 and the winter flu.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more